Guidepoint Qsight and Skytale Group Report 9% Surge in Medical Aesthetic Non-Surgical Revenues in First Half of 2024
September 25, 2024 09:00 ET
|
Guidepoint Qsight
Medical aesthetics non-surgical revenues rose 9% in H1 2024, driven by semaglutides, neurotoxins, and a growing consumer base, per Guidepoint & Skytale.
Global Neurotoxin Market Report 2023: Sector is Expected to Reach $13.1 Billion by 2028
November 09, 2023 04:43 ET
|
Research and Markets
Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The "Neurotoxin Market Forecast to 2028 - Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's...